Argitalpenak (39) Ikertzaileren baten partaidetza izan duten argitalpenak

2022

  1. A holistic approach to evaluating Parkinson's disease, using the Delphi method: a linear evaluation index

    Arquivos de Neuro-Psiquiatria, Vol. 80, Núm. 2, pp. 145-152

  2. Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy

    Translational Neurodegeneration, Vol. 11, Núm. 1

  3. An interactive framework for the detection of ictal and interictal activities: Cross-species and stand-alone implementation

    Computer Methods and Programs in Biomedicine, Vol. 218

  4. Astrogliosis in aging and Parkinson's disease dementia: a new clinical study with 11C-BU99008 PET

    Brain Communications, Vol. 4, Núm. 5

  5. Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain

    Neurology and Therapy, Vol. 11, Núm. 3, pp. 1183-1192

  6. Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

    Neurologia, Vol. 37, Núm. 5, pp. 390-402

  7. Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism

    Neurobiology of Disease, Vol. 167

  8. Cutaneous Allodynia in Migraine: A Narrative Review

    Frontiers in Neurology, Vol. 12

  9. Encapsulation of MSCs and GDNF in an Injectable Nanoreinforced Supramolecular Hydrogel for Brain Tissue Engineering

    Biomacromolecules, Vol. 23, Núm. 11, pp. 4629-4644

  10. European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure

    The journal of headache and pain, Vol. 23, Núm. 1, pp. 133

  11. European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update

    Journal of Headache and Pain, Vol. 23, Núm. 1

  12. Exploiting 4-1BB immune checkpoint to enhance the efficacy of oncolytic virotherapy for diffuse intrinsic pontine gliomas

    JCI Insight, Vol. 7, Núm. 7

  13. GABABR activation partially normalizes acute NMDAR hypofunction oscillatory abnormalities but fails to rescue sensory processing deficits

    Journal of Neurochemistry, Vol. 161, Núm. 5, pp. 417-434

  14. Grey matter changes on brain MRI in subjective cognitive decline: a systematic review

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

  15. Hydrogels for brain repair: application to Parkinson’s disease

    Expert Opinion on Drug Delivery, Vol. 19, Núm. 11, pp. 1521-1537

  16. Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea in Spain: Implementation Strategy and Early Results in a Tertiary Care Center

    Indian Journal of Otolaryngology and Head and Neck Surgery, Vol. 74, Núm. 2, pp. 158-165

  17. Immune Mechanism of Epileptogenesis and Related Therapeutic Strategies

    Biomedicines, Vol. 10, Núm. 3

  18. Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies

    Blood cancer journal, Vol. 12, Núm. 2, pp. 32

  19. Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia

    Movement Disorders Clinical Practice, Vol. 9, Núm. 4, pp. 479-483

  20. MNCD: A New Tool for Classifying Parkinson’s Disease in Daily Clinical Practice

    Diagnostics, Vol. 12, Núm. 1